Login

Anton Pillay, CEO of Coronation Fund Managers, discusses the company's adjustment to payment processes in a "#PayIn30" initiative. 00:10:00

Share On Facebook Share On Twitter

Anton Pillay, CEO of Coronation Fund Managers,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Global investment organization with one single, relentless mission|Nick Shalek,General Partner,Ribbit Capital
00:10:00
IT HAS EASY ACCESS TO SKILLED LABOR, ROADS, RAIL, POWER, NATURAL GAS AND WATER | FRANK MARASCO JR., FOUNDER, PRESIDENT AND CEO, WEST HIGH YIELD (WHY) RESOURCES LTD
00:10:00
Sandeep Biswas Managing Director & CEO, Newcrest Mining Limited|
00:10:00
Growth and Strategy Overview of Minerros, a Colombian Gold Producer
00:10:00
Interview with Robert Crayford and Keith Watson: Insights into Geiger Counter Limited and the Uranium Market
00:10:00
Understanding the Evolution and Vision of XP Inc. | Thiago Maffra, CEO , XP Inc.
00:10:00
"Culinary Success: The Journey of NIU Sushi" with CEO Alan Schoihet
00:10:00
RPM started with the foundations necessary to conquer the enterprise approach and the core belief that all systems and information|Richard Mathews,CEO,RPMGlobal Holdings Ltd
00:10:00
Driving Clean Energy Transition: A Discussion on Renewable Energy Expansion| Eric Francia, CEO, Acen Corp.
01:10:00
CEO Insights on Government Tenants and Portfolio Strategy | Roger Waesche Jr., CEO, Corporate Office Properties Trust.
00:10:00
Technical Analysis on BSPM: Key Support and Resistance Levels
00:10:00
Jean Hynes of Wellington Management on Healthcare Investing: Insights on Medical Advances, Collaborative Culture, and the Future of the Sector

© 2017 - Neuhu+